Home›People›Jonathan Foster
JF

Jonathan Foster

Chief Financial Officer at Moleculin Biotech. Also a director at Autonomix Medical.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 5, 2026·Suggest an edit

About Jonathan Foster

Jonathan Foster is a chief financial officer at Moleculin Biotech.

Form D filings name Jonathan Foster as a director at Autonomix Medical.

Jonathan Foster reports to the SEC as a director or officer of 5 public companies, including Empery Digital (EMPD), Autonomix Medical (AMIX) and Soliton (SOLY).

Jonathan Foster first appears on SEC filings in 2012.

Experience

This experience comes from SEC filings. The years are when the filings name Jonathan Foster in the role, so the role may have started earlier or lasted longer.

Moleculin Biotech, Inc.
Chief Financial Officer
2016 – 2026 · Public company (MBRX)
Empery Digital Inc.
Director
2021 – 2026 · Public company (EMPD)
Autonomix Medical, Inc.
Director
2022 – 2024 · Public company (AMIX)
Soliton, Inc.
Director
2019 – 2021 · Public company (SOLY)
InfuSystem Holdings, Inc
Chief Financial Officer
2012 – 2015 · Public company (INFU)

Key Colleagues at Startups

The people Jonathan Foster works with at each company, as listed on that company's latest Form D.

Autonomix Medical, Inc. · Form D, Jun 1, 2023
DR
David Robins
Director
ML
Matthew Lourie
Chief Financial Officer
WK
Walter Klemp
Director
RS
Robert Schwartz
Executive officer

Sources

  1. SECAutonomix Medical, Inc. Form D, filed Jun 1, 2023
  2. SECForms 3, 4 and 5 filed by Jonathan Foster (SEC filer 1545414)